Impact of viscosity and refractive index on droplet size and zeta potential of model O/W and W/O nanoemulsion

Current Nanoscience

Volumn 9, Issue 2, 2013, Pages 248-253

  Shakeel, Faiyaz ^a   Haq, Nazrul ^a   Ali, Mohd ^a   Alanazi, Fars K ^a,b   Alsarra, Ibrahim A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

5 fluorouracil; Droplet size; Indomethacin; Nanoemulsions; Refractive index; Viscosity; Zeta potential

Indexed keywords

5-FLUOROURACIL; 5-FLUOROURACIL (5-FU); DROPLET SIZES; INDOMETHACIN; NANO-EMULSIONS; POLYDISPERSITY INDICES; SETTING PARAMETERS; W/O NANO-EMULSION;

DROPS; EMULSIFICATION; VISCOSITY; ZETA POTENTIAL;

REFRACTIVE INDEX;

FLUOROURACIL; INDOMETACIN; LIPID EMULSION; WATER OIL CREAM;

ARTICLE; CHEMICAL COMPOSITION; DRUG DELIVERY SYSTEM; NANOEMULSION; PARTICLE SIZE; PRIORITY JOURNAL; REFRACTION INDEX; VISCOSITY; ZETA POTENTIAL;

EID: 84878655807     PISSN: 15734137     EISSN: 18756786     Source Type: Journal    
DOI: 10.2174/1573413711309020014     Document Type: Article

References (17)

1. Azeem, A.; Talegaonkar, S.; Negi, L.M.; Ahmad, F.J.; Khar, R.K.; Iqbal, Z. Oil based nanocarrier system for transdermal delivery of ropinirole: A mechanistic, pharmacokinetic and biochemical investigation. Int. J. Pharm., 2012, 422, 436-444.
2. Rajpoot, P.; Pathak, K.; Bali, V. Therapeutic applications of nanoemulsion based drug delivery systems: A review of patents in last two decades. Recent Pat. Drug Del. Formul., 2011, 5, 163-172.
3. Shakeel, F.; Ramadan, W.; Faisal, M.S.; Rizwan, M.; Faiyazuddin, M.; Mustafa, G.; Shafiq, S. Transdermal and topical delivery of antiinflammatory agents using nanoemulsion/microemulsion: An updated review. Curr. Nanosci., 2010, 6, 184-198.
4. Mustafa, G.; Baboota, S.; Ahuja, A.; Ali, J. Formulation development of chitosan coated intra nasal ropinirole nanoemulsion for better management option of parkinson: An in vitro and ex vivo evaluation. Curr. Nanosci., 2012, 8, 348-360.
5. McClements, D.J. Nanoemulsions versus microemulsions: Terminology, differences and similarities. Soft Matter, 2012, 8, 1719-1729.
6. Anton, N.; Vandamme, T.F. Nanoemulsions and microemulsions: Clarification of critical differences. Pharm. Res., 2011, 28, 978-985.
7. Shakeel, F.; Shafiq, S.; Haq, N.; Alanazi, F.K.; Alsarra, I.A. Nanoemulsions as potential vehicles for transdermal and dermal delivery of hydrophobic compounds: An overview. Expert Opin. Drug Deliv., 2012, 9, 953-974.
8. Bali, V.; Ali, M.; Ali, J. Nanocarrier for the enhanced bioavailability of a cardiovascular agent: In vitro, pharmacodynamics, pharmacokinetic and stability assessment. Int. J. Pharm., 2011, 403, 46-56.
9. Shafiq, S.; Shakeel, F.; Talegaonkar, S.; Ahmad, F.J.; Khar, R.K.; Ali, M. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur. J. Pharm. Biopharm., 2007, 66, 227-243.
10. Shakeel, F.; Ramadan, W. Transdermal delivery of anticancer drug caffeine from water-in-oil nanoemulsions. Coll. Surf. B: Biointerf., 2010, 75, 356-362.
11. Klang, V.; Haberfeld, S.; Hartl, A.; Valenta, C. Effect of γ-cyclodextrin on the in vitro skin permeation of a steroidal drug from nanoemulsions: Impact of experimental setup. Int. J. Pharm., 2012, 423, 535-542.
12. Klang, J.H.; Oh, D.H.; Oh, Y.K.; Yong, C.S.; Choi, HG. Effects of solid carriers on crystalline properties, dissolution and bioavailability of flurbiprofen in solid nanoemulsifying drug delivery system (solid SNEDDS). Eur. J. Pharm. Biopharm., 2012, 80, 289-297.
13. Badawi, A.A.; El-Laithy, H.M.; El-Qidra, R.K.; El-Mofty, H.; El-Dally, M. Chitosan based nanocarriers for indomethacin ocular delivery. Arch. Pharm. Res., 2008, 31, 1040-1049.
14. Ahmad, M.; Usman, M.; Madni, A.; Zubair, M.; Zaman, Q.U.; Qureshi, M.S.; Munir, A.; Ahmad, M.; Mahmood, A. A fast and simple HPLC-UV method for simultaneous determination of three anticancer agents in plasma of breast cancer patients and its application to clinical pharmacokinetics. Afr. J. Pharm. Pharmacol., 2011, 5, 915-922.
15. Bruijn, E.A.D.; Driessen, O.; Bosch, N.V.D.; Strijen, E.V.; Slee, P.H.; Oosterom, A.T.V.; Tjaden, U.R. A gas chromatographic assay for the determination of 5,6-dihydrofluorouracil and 5-fluorouracil in human plasma. J. Chromatogr., 1983, 278, 283-289.
16. Freitas, C.; Muller, R.H. Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN™) dispersions. Int. J. Pharm., 1998, 168, 221-229.
17. Craig, D.Q.M.; Barker, S.A.; Banning, D. An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy. Int. J. Pharm., 1995, 114, 103-110.